Cargando…
Development of a blood-based extracellular vesicle classifier for detection of early-stage pancreatic ductal adenocarcinoma
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) has an overall 5-year survival rate of just 12.5% and thus is among the leading causes of cancer deaths. When detected at early stages, PDAC survival rates improve substantially. Testing high-risk patients can increase early-stage cancer detection;...
Autores principales: | Hinestrosa, Juan Pablo, Sears, Rosalie C., Dhani, Harmeet, Lewis, Jean M., Schroeder, Gregor, Balcer, Heath I., Keith, Dove, Sheppard, Brett C., Kurzrock, Razelle, Billings, Paul R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587093/ https://www.ncbi.nlm.nih.gov/pubmed/37857666 http://dx.doi.org/10.1038/s43856-023-00351-4 |
Ejemplares similares
-
Case Report: Early detection of pancreatic pre-cancer lesion in multimodal approach with exosome liquid biopsy
por: Dhani, Harmeet, et al.
Publicado: (2023) -
Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test
por: Hinestrosa, Juan Pablo, et al.
Publicado: (2022) -
Focus on Extracellular Vesicles: Development of Extracellular Vesicle-Based Therapeutic Systems
por: Ohno, Shin-ichiro, et al.
Publicado: (2016) -
NF2/Merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations
por: Schroeder, Rebecca Dunbar, et al.
Publicado: (2013) -
MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance
por: Farrell, Amy S., et al.
Publicado: (2017)